Totally implantable vascular access devices for cystic fibrosis

Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions.

The introduction of totally implantable venous access devices (TIVAD) has provided a solution to difficult venous access in patients with cystic fibrosis. Early reports have, however, recognized a number of complications with their use. We report our experience with five devices used over 8 yrs with regard to complications and patient attitudes. Patients' notes were reviewed to record the detai...

Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.

BACKGROUND Totally implantable vascular access devices (TIVADs) are accepted as a safe and effective method of facilitating long term intravenous therapy. We report our experience of the use of these devices in children with cystic fibrosis with a particular focus on the incidence and type of complications. METHODS The medical records of patients with cystic fibrosis who underwent placement o...

Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients.

The use and complications of totally implantable vascular access devices (TIVADs) were examined during multiple courses of antibiotics in cystic fibrosis (CF) patients. This retrospective study involved 36 CF centres. Risk factors for removal and septicaemia were sought by survival analysis of censored data. Multivariate Cox models were constructed with removal or septicaemia as the event and t...

Applying Totally Implantable Venous Access Devices (TIVAD) in Children: the First Iranian Experience

Use of a totally implantable system for venous access in cystic fibrosis.

Pseudomonas aeruginosa is the major bronchopulmonary pathogen affecting adolescents and adults with cystic fibrosis.' It is not susceptible to any oral antimicrobial agents generally available and is conventionally treated with intravenous chemotherapy. In patients requiring frequent or prolonged treatment, however, thrombophlebitis of peripheral veins may necessitate central venous access. We ...